Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteremia | 2 | 2024 | 105 | 0.840 |
Why?
|
| Febrile Neutropenia | 1 | 2022 | 16 | 0.760 |
Why?
|
| Coinfection | 2 | 2020 | 63 | 0.710 |
Why?
|
| Hyalohyphomycosis | 1 | 2020 | 1 | 0.700 |
Why?
|
| Erythema Nodosum | 1 | 2020 | 4 | 0.700 |
Why?
|
| Lymphadenitis | 1 | 2020 | 7 | 0.690 |
Why?
|
| Bacteria, Anaerobic | 1 | 2020 | 3 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 3 | 2025 | 810 | 0.690 |
Why?
|
| Blood Culture | 1 | 2020 | 11 | 0.690 |
Why?
|
| Mediastinal Diseases | 1 | 2020 | 22 | 0.680 |
Why?
|
| Dyspnea | 1 | 2020 | 80 | 0.660 |
Why?
|
| Fever | 1 | 2020 | 130 | 0.640 |
Why?
|
| Mucor | 1 | 2018 | 3 | 0.600 |
Why?
|
| Fungemia | 1 | 2018 | 15 | 0.590 |
Why?
|
| Catheter-Related Infections | 1 | 2018 | 22 | 0.590 |
Why?
|
| Mucormycosis | 1 | 2018 | 18 | 0.590 |
Why?
|
| Central Venous Catheters | 1 | 2018 | 21 | 0.580 |
Why?
|
| Neoplasms | 2 | 2022 | 3117 | 0.490 |
Why?
|
| Antifungal Agents | 3 | 2022 | 125 | 0.480 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 923 | 0.470 |
Why?
|
| Syphilis, Congenital | 2 | 2025 | 9 | 0.460 |
Why?
|
| Child | 7 | 2024 | 7334 | 0.430 |
Why?
|
| Hospitals, Pediatric | 2 | 2025 | 127 | 0.260 |
Why?
|
| Retrospective Studies | 6 | 2025 | 9703 | 0.260 |
Why?
|
| Penicillins | 1 | 2025 | 24 | 0.240 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2024 | 25 | 0.220 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 120 | 0.220 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2024 | 80 | 0.200 |
Why?
|
| Staphylococcal Infections | 1 | 2024 | 279 | 0.180 |
Why?
|
| Humans | 12 | 2025 | 92337 | 0.180 |
Why?
|
| Itraconazole | 1 | 2020 | 11 | 0.170 |
Why?
|
| Mediastinum | 1 | 2020 | 48 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2020 | 69 | 0.170 |
Why?
|
| Antibody Formation | 1 | 2020 | 171 | 0.170 |
Why?
|
| Posture | 1 | 2020 | 124 | 0.170 |
Why?
|
| Leg | 1 | 2020 | 139 | 0.170 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 64 | 0.160 |
Why?
|
| Prednisone | 1 | 2020 | 254 | 0.160 |
Why?
|
| Respiratory System | 1 | 2020 | 119 | 0.160 |
Why?
|
| Antibodies, Viral | 1 | 2020 | 302 | 0.150 |
Why?
|
| Hospitalization | 2 | 2024 | 927 | 0.150 |
Why?
|
| Intestinal Pseudo-Obstruction | 1 | 2018 | 7 | 0.150 |
Why?
|
| Jejunostomy | 1 | 2018 | 14 | 0.150 |
Why?
|
| Amphotericin B | 1 | 2018 | 37 | 0.150 |
Why?
|
| Immunocompetence | 1 | 2018 | 27 | 0.150 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 62 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2020 | 367 | 0.140 |
Why?
|
| Inpatients | 1 | 2021 | 331 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2021 | 473 | 0.130 |
Why?
|
| Lymph Nodes | 1 | 2020 | 552 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 1592 | 0.130 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 328 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 313 | 0.120 |
Why?
|
| Lung | 1 | 2020 | 1337 | 0.110 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 3775 | 0.100 |
Why?
|
| Prognosis | 1 | 2020 | 3872 | 0.100 |
Why?
|
| Male | 5 | 2025 | 43925 | 0.100 |
Why?
|
| Risk Factors | 1 | 2022 | 5704 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 2680 | 0.080 |
Why?
|
| Infant, Newborn | 2 | 2025 | 2517 | 0.070 |
Why?
|
| Adolescent | 1 | 2020 | 9504 | 0.070 |
Why?
|
| Pregnancy | 2 | 2025 | 3110 | 0.070 |
Why?
|
| United States | 3 | 2025 | 7348 | 0.060 |
Why?
|
| Health Information Systems | 1 | 2025 | 7 | 0.060 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2024 | 9 | 0.060 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 122 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2020 | 70 | 0.040 |
Why?
|
| Child, Hospitalized | 1 | 2021 | 38 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2025 | 955 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 126 | 0.040 |
Why?
|
| Caregivers | 1 | 2021 | 177 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 460 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 891 | 0.040 |
Why?
|
| Infant | 1 | 2025 | 3218 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 269 | 0.030 |
Why?
|
| Sleep | 1 | 2021 | 461 | 0.030 |
Why?
|
| Female | 3 | 2025 | 47893 | 0.030 |
Why?
|
| Pandemics | 1 | 2020 | 812 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 27030 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 27532 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2020 | 8740 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 19943 | 0.010 |
Why?
|